Last reviewed · How we verify

NCT05177705

The Intersection Between Loss of Control Eating and Obesity: The Role of Restriction and Food Reinforcement

Completed NA Last updated 8 July 2025
What this trial tests

NA trial testing Restricted access task in Pediatric Obesity in 126 participants. Completed in 22 May 2025.

Timeline
11 November 2021
Primary endpoint
22 May 2025
22 May 2025

Quick facts

Lead sponsorState University of New York at Buffalo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment126
Start date11 November 2021
Primary completion22 May 2025
Estimated completion22 May 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

State University of New York at Buffalo

Who can join

Adults 8 to 11, any sex, with Pediatric Obesity or Nutrition Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine the relationships among loss of control eating, restriction, relative reinforcing value of high energy-dense food, and obesity risk. In order to achieve this aim, the investigators will follow children over the course of a year, obtaining behavioral and observational measurements, in addition to a two-week restricted access and two week non-restricted access period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pediatric Obesity

Currently open trials in the same condition.

Other State University of New York at Buffalo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05177705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing